QR Code

Tau biology, biomarkers, and therapeutics

Abstract As Alzheimer's disease (AD) research advances, tau has emerged as both a critical biomarker and a promising therapeutic target, central to understanding disease mechanisms, tracking progression, and guiding treatment development. The Fall 2024 Alzheimer's Association Research Roundtable con...

Full description

Saved in:
Main Authors: Bess Frost, Hartmuth Kolb, Alicia Algeciras‐Schimnich, Tobey J. Betthauser, Sarah DeVos, Rebecca M. Edelmayer, Fiona Elwood, Adam S. Fleisher, David Henley, Kanta Horie, Bradley Hyman, William Charles Kreisl, Luka Kulic, Antoine Leuzy, Jose‐Alberto Palma, Sophie Parmentier‐Batteur, Maria‐Magdalena Patru, Gil D. Rabinovici, Larisa Reyderman, Reisa A. Sperling, Serge Van Der Geyten, Kristin R. Wildsmith, Simin Mahinrad, Maria C. Carrillo, Christopher J. Weber
Format: Artigo
Language:Inglês
Published: Wiley 2025-10-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease staging
Alzheimer's disease treatments
amyloid
AUC
biomarker
clinical trials
Online Access:https://doi.org/10.1002/trc2.70165
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items